EPA and DHA: potential pathways for antiatherogenesis. The boxes emphasize mechanisms of action where EPA/DHA may decrease the development of atherosclerosis. LDLox, oxidized LDL; LpL, lipoprotein lipase; Lt, leukotriene; SMC, smooth muscle cell; Tx, thromboxane; VCAM-1, vascular cell adhesion molecule 1.